Literature DB >> 1672916

Topical BCG for recurrent superficial bladder cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1672916

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Immunomodulators. Future prospects.

Authors:  B C Takx-Köhlen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

2.  Pulmonary tuberculosis due to bacille Calmette-Guérin.

Authors:  D Kirsten; U Rieger; K H Schröder; A Böhle; H Magnussen
Journal:  Clin Investig       Date:  1993-10

3.  Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer.

Authors:  A M Nouri; R Hyde; R T Oliver
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

4.  Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapy.

Authors:  M Zembala; A Czupryna; J Wieckiewicz; M Jasinski; J Pryjma; I Ruggiero; M Siedlar; T Popiela
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

5.  Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies.

Authors:  A M Nouri; A V dos Santos; D Crosby; R T Oliver
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.